Acquisition by Adam Levy of 200000 shares of Mineralys Therapeutics at 14.25 subject to Rule 16b-3
NXGL Stock | USD 3.83 0.63 14.13% |
About 61% of Nexgel's investor base is looking to short. The analysis of overall sentiment of trading Nexgel Inc stock suggests that many investors are alarmed at this time. Nexgel's investing sentiment shows overall attitude of investors towards Nexgel Inc.
Nexgel |
Filed transaction by Mineralys Therapeutics Common Officer Cfo And Secretary. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Nexgel Fundamental Analysis
We analyze Nexgel's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexgel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexgel based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Nexgel is currently under evaluation in target price category among its peers.
Nexgel Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nexgel stock to make a market-neutral strategy. Peer analysis of Nexgel could also be used in its relative valuation, which is a method of valuing Nexgel by comparing valuation metrics with similar companies.
Peers
Nexgel Related Equities
POAI | Predictive Oncology | 30.43 | ||||
ZJYL | JIN MEDICAL | 5.21 | ||||
STSS | Sharps Technology | 5.21 | ||||
DXR | Daxor | 2.91 | ||||
LUCY | Innovative Eyewear | 2.78 | ||||
PDEX | Pro Dex | 1.36 | ||||
NYXH | Nyxoah | 1.22 | ||||
MLSS | Milestone Scientific | 1.06 | ||||
AVGR | Avinger | 2.41 | ||||
GCTK | GlucoTrack | 9.38 |
Check out Nexgel Hype Analysis, Nexgel Correlation and Nexgel Performance. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.